Investigating the impact of alcohol use on HIV treatment in sub-Saharan Africa
CHARTZ
This study is looking at a new way to help people in sub-Saharan Africa who are living with HIV and also have problems with alcohol use, by using a treatment called CETA that can be provided by trained community members, making it easier for more people to get the support they need.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10915740 on NIH RePORTER |
What this research studies
This research focuses on the intersection of unhealthy alcohol use and HIV infection, particularly in sub-Saharan Africa where both issues are prevalent. It aims to evaluate a treatment approach called the Common Elements Treatment Approach (CETA), which is designed to be delivered by lay providers to help individuals with HIV who also struggle with alcohol use. The study will assess the effectiveness of this approach over a series of therapy sessions, addressing both alcohol use and mental health conditions. By utilizing non-professionals for delivery, the research seeks to improve access to effective interventions in regions with limited mental health resources.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV in sub-Saharan Africa who also engage in unhealthy alcohol use.
Not a fit: Patients who do not have HIV or do not engage in unhealthy alcohol use may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide effective, accessible treatment options for individuals with HIV and unhealthy alcohol use, potentially improving their overall health outcomes.
How similar studies have performed: Previous trials have shown that the CETA approach can be effective for various conditions in marginalized populations, indicating potential for success in this context.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Vinikoor, Michael Jeffrey — University of Alabama at Birmingham
- Study coordinator: Vinikoor, Michael Jeffrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.